Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleotide-based prodrugs

Nucleotide-based prodrugs

US Patent 6610841 · Granted Aug 26, 2003

Estimated economic value: $126,925,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating disorders with Group I mGluR antagonists2010
Method and identification of downstream mRNA ligands to FMRP and their role in f2008
Tenascin-C nucleic acid ligands2006
Methods of treating disorders with Group I mGluR antagonists2005
Methods of treating disorders with group I mGluR antagonists2005
Tenascin-C nucleic acid ligands2003
Tenascin-C nucleic acid ligands2001
Diagnosis of the fragile X syndrome2001
Diagnosis of the fragile X syndrome2000